Which diabetes stocks are poised to benefit from this ongoing innovation bonanza? AstraZeneca (NYSE:AZN), Eli Lilly (NYSE:LLY), and Medtronic (NYSE:MDT) are three names that our Motley Fool healthcare contributors think are worth keeping tabs on this month.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,